English | Español

Technology/Innovation
+ Technology/Innovation
Jamie Barrand | Dec 12, 2015

Eisai revises indicated uses for Neuzym medication
+ Technology/Innovation
Jamie Barrand | Dec 12, 2015

ALS Association grants funding to nine different ALS studies
+ Technology/Innovation
Jamie Barrand | Dec 12, 2015

Onconova scientists present rigosertib data at American Society of Hemotology's 57th annual meeting
+ Technology/Innovation
Jamie Barrand | Dec 12, 2015

BioBlast researchers develop new therapies for oculopharyngeal muscular dystrophy
+ Technology/Innovation
Jamie Barrand | Dec 12, 2015

Astellas researchers release results of Cresemba study
+ Technology/Innovation
Jamie Barrand | Dec 12, 2015

FDA grant to fund NORD rare disease studies
+ Technology/Innovation
Jamie Barrand | Dec 11, 2015

Baxalta receives FDA approval for von Willebrand disease treatment
+ Technology/Innovation
Jamie Barrand | Dec 11, 2015

Merck presents Keytruda study results at American Society of Hematology meeting

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation